AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- Open
- $27.55
- 52-wk high
- $65.30
- High
- $31.27
- 52-wk low
- $13.74
- Low
- $27.41
- Prev close
- $31.09
Smart money
Earnings
Earnings came in $0.03 a share below what analysts expected.
Financials
What it sold, what it cost, what was left.
Jun 2025Sep 2025Dec 2025Mar 2026
| USD | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $544.8M | $599.0M | $617.8M | $608.1M |
| Cost of what it sold | $128.6M | $156.9M | $173.4M | $307.8M |
| Gross profit | $416.2M | $442.1M | $444.4M | $300.3M |
| What it spent | ||||
| Research and development | $37.8M | $40.6M | $41.0M | $46.9M |
| Sales and admin | $67.3M | $80.7M | $76.2M | $109.7M |
| Other operating costs | $284.4M | $309.0M | $318.1M | $160.1M |
| Total operating expenses | $389.5M | $430.3M | $435.2M | $316.8M |
| What was left | ||||
| Operating profit | $26.7M | $11.8M | $9.2M | -$16.5M |
| Profit before tax | $32.9M | $12.2M | $18.4M | -$101.6M |
| Tax | -$9.7M | -$3.6M | -$2.2M | -$9.4M |
| Net profit | $42.5M | $15.8M | $20.6M | -$92.1M |
| EBITDA | $43.3M | $29.9M | $36.4M | -$79.6M |
Technicals
Price structure
This stock is trending upward.
Trend
Constructive
60 / 100
RSI 14
61balanced
20D volatility
119%annualized
52-week range
$13.74$65.30
20D support
News
What the news says
18 articles · 7 days
Coverage is bearish
Tone of tracked coverage
Hims & Hers Director Kare Schultz Granted 8,223 RSUs on August 12, 2026
NeutralAug 14Kaplan Fox is Investigating Hims & Hers Health, Inc. (NYSE: HIMS) for Potential Securities Law Violations
BearishAug 14FTC lawsuit alleges Hims & Hers charged consumers for unwanted prescriptions
BearishAug 13
